Cargando…
Short-term assays for mesenchymal stromal cell immunosuppression of T-lymphocytes
INTRODUCTION: Trauma patients are susceptible to coagulopathy and dysfunctional immune responses. Mesenchymal stromal cells (MSCs) are at the forefront of the cellular therapy revolution with profound immunomodulatory, regenerative, and therapeutic potential. Routine assays to assess immunomodulatio...
Autores principales: | Herzig, Maryanne C., Christy, Barbara A., Montgomery, Robbie K., Cantu-Garza, Carolina, Barrera, Gema D., Lee, Ji H., Mucha, Nicholas, Talackine, Jennifer R., Abaasah, Isaac A., Bynum, James A., Cap, Andrew P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562633/ https://www.ncbi.nlm.nih.gov/pubmed/37822938 http://dx.doi.org/10.3389/fimmu.2023.1225047 |
Ejemplares similares
-
Neglected No More: Emerging Cellular Therapies in Traumatic Injury
por: Lowry, Lacy E., et al.
Publicado: (2021) -
Similar hemostatic responses to hypovolemia induced by hemorrhage and lower body negative pressure reveal a hyperfibrinolytic subset of non-human primates
por: Zaar, Morten, et al.
Publicado: (2020) -
Intravenous administration of mesenchymal stromal cells leads to a dose-dependent coagulopathy and is unable to attenuate acute traumatic coagulopathy in rats
por: Wu, Xiaowu, et al.
Publicado: (2022) -
Tissue Source and Cell Expansion Condition Influence Phenotypic Changes of Adipose-Derived Stem Cells
por: Mangum, Lauren H., et al.
Publicado: (2017) -
Mesenchymal stromal cell delivery via an ex vivo bioreactor preclinical test system attenuates clot formation for intravascular application
por: O'Rourke, Brian, et al.
Publicado: (2021)